Electra Therapeutics (ETRA) vs Valneva (VALN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Electra Therapeutics is the larger company by market cap ($553.0 million vs $538.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETRA | VALN |
|---|---|---|
| Share price | $8.81 | $5.68 |
| Market cap | $552.98M | $538.12M |
| 1-day change | -3.82% | -3.32% |
| YTD return | — | -33.45% |
| 1-year return | — | -44.88% |
| 5-year return | — | -79.07% |
| Forward P/E | — | 4.77 |
| EPS (TTM) | $-2.65 | $-2.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.50 | $12.18 |
| 52-week low | $8.63 | $4.75 |
| Distance from 52-week high | -43.16% | -53.41% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +115.86% |
| Average volume | 948.89K | 78.15K |
| Shares outstanding | 62.77M | 94.82M |
| Employees | 46 | 620 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Electra Therapeutics
ETRA stock →Electra Therapeutics, Inc. is a clinical-stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees
About Valneva
VALN stock →Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 620 employees
ETRA vs VALN FAQ
Which is bigger, Electra Therapeutics or Valneva?
Electra Therapeutics (ETRA) is larger, with a market capitalization of $552.98M compared with $538.12M for Valneva (VALN).
Are Electra Therapeutics and Valneva in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.